{
  "2019_Pipeline_Status":[
    {
      "Phase": "Phase 1",
      "NCT #": "NCT02353598",
      "Drug Name": "crenezumab",
      "Status": "Completed (terminated?)",
      "Biomarkers": "PET",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": 1,
      "Geography": ""
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03522129",
      "Drug Name": "CT1812 (Elayta)",
      "Status": "Recruiting",
      "Biomarkers": "PET",
      "MOA Class": 3,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": 1
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03752294",
      "Drug Name": "Dabigatran",
      "Status": "Not yet recruiting",
      "Biomarkers": "PET or CSF",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "K",
      "Geography": 1
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03757325",
      "Drug Name": "DNL747",
      "Status": "Ongoing",
      "Biomarkers": "CSF or PET",
      "MOA Class": 3,
      "MOA Category": "c, f",
      "CADRO MOA Category": "F",
      "Geography": "1, 3"
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03706885",
      "Drug Name": "Efavirenz",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "a",
      "CADRO MOA Category": "F (infection/immunity)",
      "Geography": 1
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03274817",
      "Drug Name": "Escitalopram, Venlafaxine",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 1,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": 1
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT02600130",
      "Drug Name": "hMSCs (Longeveron Mesenchymal Stem Cells)",
      "Status": "Ongoing",
      "Biomarkers": "PET",
      "MOA Class": "stem cell",
      "MOA Category": "g",
      "CADRO MOA Category": "NGB",
      "Geography": 1
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT02462161",
      "Drug Name": "Insulin aspart Intranasal",
      "Status": "Completed",
      "Biomarkers": "No",
      "MOA Class": 3,
      "MOA Category": "d",
      "CADRO MOA Category": "J",
      "Geography": ""
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03838185",
      "Drug Name": "J147",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "M",
      "Geography": 1
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03375697",
      "Drug Name": "JNJ-63733657",
      "Status": "Ongoing",
      "Biomarkers": "CSF",
      "MOA Class": 4,
      "MOA Category": "b",
      "CADRO MOA Category": "B",
      "Geography": 3
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT03668405",
      "Drug Name": "Lu AF20513",
      "Status": "Terminated (based on new efficacy data from another study",
      "Biomarkers": "no",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 1",
      "NCT #": "NCT02388152",
      "Drug Name": "Lu AF20513",
      "Status": "Terminated (based on new efficacy data from another study",
      "Biomarkers": "CSF",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 1|Phase 2",
      "NCT #": "NCT03172117",
      "Drug Name": "hUCB-MSCs (human umbilical cord blood derived mesenchymal stem cells) NEUROSTEM",
      "Status": "Recruiting, extension",
      "Biomarkers": "no",
      "MOA Class": "stem cell",
      "MOA Category": "g",
      "CADRO MOA Category": "NGB",
      "Geography": 5
    },
    {
      "Phase": "Phase 1|Phase 2",
      "NCT #": "NCT02672306",
      "Drug Name": "Human UCMSCs (Human Umbilical Cord-Derived Mesenchymal Stem Cells)",
      "Status": "Ongoing",
      "Biomarkers": "No",
      "MOA Class": "stem cell",
      "MOA Category": "g",
      "CADRO MOA Category": "NGB",
      "Geography": 5
    },
    {
      "Phase": "Phase 1|Phase 2",
      "NCT #": "NCT03186989",
      "Drug Name": "IONIS MAPTRx (BIIB080)",
      "Status": "Recruiting",
      "Biomarkers": "CSF",
      "MOA Class": 4,
      "MOA Category": "b",
      "CADRO MOA Category": "NGB (but include in main table and solar per Dr.C)",
      "Geography": "1, 3"
    },
    {
      "Phase": "Phase 1|Phase 2",
      "NCT #": "NCT03069014",
      "Drug Name": "LM11A-31-BHS",
      "Status": "Recruiting",
      "Biomarkers": "CSF",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "L",
      "Geography": "3, 4"
    },
    {
      "Phase": "Phase 1|Phase 2",
      "NCT #": "NCT02925650",
      "Drug Name": "Posiphen",
      "Status": "Recruiting",
      "Biomarkers": "CSF",
      "MOA Class": 3,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": 1
    },
    {
      "Phase": "Phase 1|Phase 2",
      "NCT #": "NCT03101085",
      "Drug Name": "S-equol (AUS-131)",
      "Status": "Recruiting",
      "Biomarkers": "No",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "L or M?",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02579252",
      "Drug Name": "AADvac1",
      "Status": "Completed",
      "Biomarkers": "CSF",
      "MOA Class": 4,
      "MOA Category": "b",
      "CADRO MOA Category": "B",
      "Geography": ""
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03712787",
      "Drug Name": "ABBV-8E12",
      "Status": "Enrolling by invitation - Extension study",
      "Biomarkers": "no",
      "MOA Class": 4,
      "MOA Category": "b",
      "CADRO MOA Category": "B",
      "Geography": "1, 3, 7"
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02880956",
      "Drug Name": "ABBV-8E12",
      "Status": "Ongoing",
      "Biomarkers": "PET",
      "MOA Class": 4,
      "MOA Category": "b",
      "CADRO MOA Category": "B",
      "Geography": "1, 3, 6, 7"
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03461276",
      "Drug Name": "ABvac40",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": 3
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03790982",
      "Drug Name": "AD-35",
      "Status": "Active, not recruiting",
      "Biomarkers": "no",
      "MOA Class": 1,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": 5
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03625401",
      "Drug Name": "AD-35",
      "Status": "Recruiting",
      "Biomarkers": "no",
      "MOA Class": 1,
      "MOA Category": "e",
      "CADRO MOA Category": "D",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03639987",
      "Drug Name": "Aducanumab (EVOLVE)",
      "Status": "Terminated (based on futility analysis conducted on Phase 3 trials and not based on safety concerns)",
      "Biomarkers": "PET",
      "MOA Class": 4,
      "MOA Category": "a",
      "CADRO MOA Category": "",
      "Geography": ""
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03533257",
      "Drug Name": "AMX0035 (combination of Tauroursodeoxycholic Acid and Sodium Phenylbutyrate)",
      "Status": "Recruiting",
      "Biomarkers": "PET or CSF, FDG-PET or vMRI",
      "MOA Class": 3,
      "MOA Category": "c",
      "CADRO MOA Category": "M, H",
      "Geography": 1
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT02756858",
      "Drug Name": "ANAVEX2-73",
      "Status": "Ongoing-extension",
      "Biomarkers": "No",
      "MOA Class": 3,
      "MOA Category": "a, b, f",
      "CADRO MOA Category": "F, M",
      "Geography": 7
    },
    {
      "Phase": "Phase 2",
      "NCT #": "NCT03806478",
      "Drug Name": "APH-1105",
      "Status": "Not yet recruiting",
      "Biomarkers": "CT or MRI",
      "MOA Class": 3,
      "MOA Category": "a",
      "CADRO MOA Category": "A",
      "Geography": 1
    }
  ]
}